Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR

Recent studies indicate that uPAR acts a crucial part in cell migration and the modulation of bone homeostasis. As a natural serine protease inhibitor, ulinastatin owns the capacity to reduce proinflammatory factors, downregulate the activation of NF-κB and mitogen-activated protein kinases (MAPKs)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Huang, Jun-ming, Ren, Ran-yue, Bao, Yuan, Guo, Jia-chao, Xiang, Wei, Jing, Xing-zhi, Shi, Jia, Zhang, Guo-xiang, Li, Long, Tian, Yong, Kang, Hao, Guo, Feng-jin
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6137085/
https://ncbi.nlm.nih.gov/pubmed/30245631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados